SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Revenue Recognition (Details) - Customer |
6 Months Ended | |
---|---|---|
Jun. 30, 2021 |
Jun. 30, 2020 |
|
Five Customers [Member] | Revenues [Member] | Customer Concentration Risk [Member] | ||
Revenue Recognition [Abstract] | ||
Number of customers | 5 | |
Percentage of consolidated revenues | 85.00% | |
Three Customers [Member] | Revenues [Member] | Customer Concentration Risk [Member] | ||
Revenue Recognition [Abstract] | ||
Number of customers | 3 | |
Percentage of consolidated revenues | 81.00% | |
Biotest License Agreement [Member] | ||
Revenue Recognition [Abstract] | ||
Amortization period | 22 years |
X | ||||||||||
- Definition Remaining amortization period of deferred revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
X | ||||||||||
- Definition Number of customers accounted for company's total accounts receivable. No definition available.
|
X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|